8-24953563-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006158.5(NEFL):​c.1402G>A​(p.Asp468Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,613,980 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00087 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 5 hom. )

Consequence

NEFL
NM_006158.5 missense

Scores

1
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 7.42
Variant links:
Genes affected
NEFL (HGNC:7739): (neurofilament light chain) Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008]
MIR6841 (HGNC:50070): (microRNA 6841) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007828772).
BP6
Variant 8-24953563-C-T is Benign according to our data. Variant chr8-24953563-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 66676.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-24953563-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000867 (132/152324) while in subpopulation SAS AF= 0.00248 (12/4830). AF 95% confidence interval is 0.00143. There are 0 homozygotes in gnomad4. There are 61 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEFLNM_006158.5 linkc.1402G>A p.Asp468Asn missense_variant Exon 3 of 4 ENST00000610854.2 NP_006149.2 P07196
MIR6841NR_106900.1 linkn.*233G>A downstream_gene_variant
MIR6841unassigned_transcript_1462 n.*233G>A downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEFLENST00000610854.2 linkc.1402G>A p.Asp468Asn missense_variant Exon 3 of 4 1 NM_006158.5 ENSP00000482169.2 P07196
MIR6841ENST00000637129.1 linkn.*233G>A downstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.000867
AC:
132
AN:
152206
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00148
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00130
AC:
323
AN:
248962
Hom.:
3
AF XY:
0.00150
AC XY:
202
AN XY:
135100
show subpopulations
Gnomad AFR exome
AF:
0.0000647
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00358
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00281
Gnomad FIN exome
AF:
0.000604
Gnomad NFE exome
AF:
0.00145
Gnomad OTH exome
AF:
0.00232
GnomAD4 exome
AF:
0.00146
AC:
2129
AN:
1461656
Hom.:
5
Cov.:
32
AF XY:
0.00147
AC XY:
1070
AN XY:
727098
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.00341
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00290
Gnomad4 FIN exome
AF:
0.000506
Gnomad4 NFE exome
AF:
0.00147
Gnomad4 OTH exome
AF:
0.00154
GnomAD4 genome
AF:
0.000867
AC:
132
AN:
152324
Hom.:
0
Cov.:
33
AF XY:
0.000819
AC XY:
61
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00248
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.00148
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00122
Hom.:
0
Bravo
AF:
0.000839
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000255
AC:
1
ESP6500EA
AF:
0.00181
AC:
15
ExAC
AF:
0.00134
AC:
162
Asia WGS
AF:
0.000866
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

NEFL: BP4, BS1:Supporting -

Jan 24, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 12566280, 22765307, 17052987) -

not specified Benign:1
-
Inherited Neuropathy Consortium
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Aug 10, 2020
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Charcot-Marie-Tooth disease type 1F Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Charcot-Marie-Tooth disease type 2E Benign:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
23
DANN
Benign
0.90
DEOGEN2
Benign
0.36
T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0078
T
PrimateAI
Benign
0.45
T
Sift4G
Benign
0.38
T
Polyphen
0.037
B
Vest4
0.24
MVP
0.63
GERP RS
5.9
Varity_R
0.18
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs57153321; hg19: chr8-24811077; API